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Abstract
Objective. To evaluate the evidence for the influence of obesity as a risk factor for the
occurrence of osteoarthritis (OA) of the hip.
Methods. A bibliographical search of Medline, EMBASE and the Cochrane library until April
2000 was carried out. Articles describing studies of the relationship between obesity and the
occurrence of hip OA were selected. The quality of the studies was assessed with a standardized
set of criteria. The outcome of the studies was compared with respect to study characteristics and
the quality score for the study. A best-evidence synthesis was used to summarize the results of the
individual studies.
Results. Five longitudinal and seven cross-sectional studies were included in this review.
There was no association between outcome and study design or methodological quality. The
associations between obesity and hip OA were, however, stronger in studies in which the
diagnosis of hip OA was based not only on radiological criteria but also on clinical symptoms.
Overall, moderate evidence was found for a positive association between obesity and the
occurrence of hip OA, with an odds ratio of approximately 2.
Conclusion. The evidence for a positive influence of obesity on the development of hip OA is
moderate.
Osteoarthritis (OA) of the hip is a major cause of
morbidity and disability in the elderly. This problem
increases with the current ageing of the population in
western societies. In addition to the pain and discomfort
it causes, OA has major economic consequences w1x.
Studies in Europe have estimated that approximately
7–25% of Caucasian individuals over the age of 55 yr
suffer from hip OA; these estimates vary due to differ-
ences in the definition of OA or the selection of the
study population. The prevalence of hip OA appears
to be lowest in Asians, followed by African black and
Native American populations, and is highest in white
Europeans w2–5x. Over the last two decades many
epidemiological studies have investigated the determi-
nants of OA. These studies are important if we are to
improve our understanding of the mechanisms lead-
ing to OA and to determine whether (modifiable) risk
factors exist for which preventive interventions can be
developed and investigated.
A frequently studied object of interest is weight, or
body mass index (BMI), and its relationship with OA.
A review published in 1998 showed that people with a
higher BMI are more prone to the development of knee
OA. However, due to sparse data and inconsistencies in
the reported studies, the impact of obesity on hip OA
was less clear w2x.
Because several new studies investigating the relation-
ship between hip OA and obesity have been published,
we decided to investigate this topic using modern
methods for systematically identifying and assessing
the available studies. The result may be of consider-
able practical and theoretical importance for the
management of this disease, including preventive
measures.
Methods
Identification and selection of the literature
To identify observational studies on this subject, rele-
vant publications were searched using the following
databases: Medline (1966 to April 2000), Cochrane
library (1993 to April 2000) and EMBASE (1980 to
April 2000). The following key words were used: whip
and (arthritis or arthrosis or osteoarthritis or osteo-
arthrosis) or coxarthrosisx and (risk factor or causative or
determinants or predictor or aetiology) and (case–control
or retrospective or prospective or longitudinal or follow
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up or cohort). (A detailed list of the key words used
can be obtained from the corresponding author.)
We optimized the search strategy by looking at the
specificity and sensitivity of different strategies. We tried
to be as sensitive as possible within the bounds of
feasibility, because of difficulty in finding the right key
words and the different types of design. The search was
extended by screening the reference lists of all relevant
articles identified.
A study was eligible for inclusion if it fulfilled all of
the following criteria: (i) one of the aims of the study
was to investigate an association between hip OA and
obesity; (ii) the article was written in English, Dutch,
German, French, Danish, Norwegian or Swedish; (iii)
the article was a full-text article; (iv) the patients in the
studies had to suffer from radiological anduor clinical
hip OA, had had a (total) hip replacement (THR) or
were on the waiting list for one; and (v) the study was of
a cohort, case–control or cross-sectional design.
A study was excluded if the studied population had a
specific underlying pathology, such as trauma (fractures),
infection, rheumatoid arthritis, ankylosing spondylitis,
Perthes’ disease, tuberculosis, haemochromatosis, sickle
cell disease, Cushing’s disease or femoral head necrosis.
Publication bias
Identification of all relevant articles is crucial to the
validity of a systematic review w6x. The amount of
potential publication bias in our study was analysed by
means of a funnel plot, in which the study outcome was
plotted against the sample size of the study. In the
absence of publication bias, the plot will resemble a
symmetrical inverted funnel w7x; because of the small
number of studies included and the lack of the required
data we could not perform a test for symmetry, so we
visually examined the funnel plot for symmetry.
Methodological quality assessment
The methodological quality of observational studies
can vary considerably, which may influence the results
and conclusions of the studies at issue and consequently
also the results and conclusions of a systematic review.
Therefore, the quality of each included paper was
assessed using the following method. Two reviewers
(AML and SMABZ) independently scored the quality
of the selected papers according to a standardized set
of criteria (Table 1). These criteria have been used in
previous reviews of observational studies in the field
of musculoskeletal disorders w8–10x and were modified
to cover the topic of our review. The criteria concern
both the internal validity and the informativeness of
the study. Only items reflecting the internal validity
of the studies were used to assess the methodological
quality.
In case of disagreement, both reviewers tried to
achieve consensus; if the disagreement was not resolved,
a third reviewer (BWK) was consulted in order to
achieve a final judgement.
Several items are not applicable to certain types of
study design (e.g. cohort or case–control study), and
therefore do not contribute to the total score of that
particular study. This means that the maximum score
(100%) for each study was based only on the items
applicable to that particular type of study design.
TABLE 1. List of criteria for the assessment of the methodological quality for cohort and case–control studies w8x
Item Criterion VuIa CHuCCb
Study population
1 Selection before disease was present or at uniform point V CHuCC
2 Cases and controls were drawn from the same population V CC
3 Participation rate 080% for casesucohort V CHuCC
4 Participation rate 080% for controls V CC
5 Sufficient description of baseline characteristics I CHuCC
Assessment of risk factor
6 Exposure assessment was blinded V CHuCC
7 Exposure was measured identical for cases and controls V CC
8 Exposure was assessed prior to the outcome V CHuCC
Assessment of hip OA
9 Hip OA was assessed identical in studied population V CHuCC
10 Presence of hip OA was assessed reproducibly V CHuCC
11 Presence of hip OA was according to valid definitions w38, 39x V CHuCC
12 Classification was standardized w40–42x I CHuCC
Study design
13 Prospective design was used V CHuCC
14 Follow-up time 03 yr V CH
15 Withdrawals (20% V CH
16 Information on completers vs withdrawals I CH
Analysis and data presentation
17 Frequencies of most important outcomes were given I CHuCC
18 Appropriate analysis techniques were used V CHuCC
19 Adjusted for at least age and gender V CHuCC
aV is a criterion of validityuprecision; I is a criterion of informativeness.
bCH, applicable to cohort studies; CC, applicable to case–control studies.
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Positive scores were summed to give an overall internal
validity score.
Best evidence synthesis
Because the observational studies were considered to be
heterogeneous with regard to the population studied,
methodological quality and determinants and outcome
measures for hip OA, we followed standard practice
and refrained from statistically pooling the data and
performed a ‘best evidence’ synthesis w8, 11–14x. First,
the studies were classified according to the type of study
design. A prospective cohort study was judged as the
preferred design, followed by a case–control study, and
then by a cross-sectional study. After that, the studies
were ranked according to their methodological quality
score. The following ranking of the levels of evidence
was formulated w8, 10, 11x:
(1)Strong evidence is provided by generally consistent
findings in multiple high-quality cohort studies.
(2)Moderate evidence is provided by general consistent
findings
in one high-quality cohort study and two or more
high quality case–control studies or
in three or more high-quality case–control studies.
(3)Limited evidence is provided by (general consistent)
findings
in a single cohort study,
in one or two case–control studies or
in multiple cross-sectional studies.
(4)Conflicting evidence is provided by conflicting
findings (i.e.<75% of the studies reported consistent
findings).
(5)Noevidence is providedwhenno studies couldbe found.
A study was considered to be of high quality if the
methodological quality score was060%. This level was
chosen at the mean of all quality scores w15x.
Data extraction
Two researchers (AML and SMABZ) collected the
characteristics of the included studies independently of
each other. They collected items on the definition of the
study population, how the presence or absence of hip
OA was assessed, the assessment of obesity, if the study
corrected for potential confounding factors and which
results were reported.
When a study reported several outcomes because of
a division of the study population into subgroups,
the separate outcomes were combined (where possible)
using Mantel Haenszel statistics, by methods described
by Clayton and Hills w16x or the method described by
Tan et al. w17x as appropriate.
Results
Identification and selection of the literature
A total of 2921 references were identified initially;
of these, only nine articles met our selection criteria
w4, 18–25x. The most frequent reasons for failing to meet
our criteria were that there was not an appropriate study
design (case reports, no data on the control group) or
no specific information about the relationship between
obesity and hip OA.
After screening the reference lists of the selected
studies, another four studies were included w26–29x. All
of them were indexed in Medline but used other
descriptions of the study design. Hartz et al. used the
term ‘health survey’ w26x and van Saase et al. used the
term ‘epidemiological survey’ w28x. The other two studies
did not specify the study design w27, 29x. We tried to
optimize the search strategy by deleting the type of study
design as one of the required key words. This improved
the sensitivity, but the specificity would then have been
too low (4431 instead of 1513 hits in Medline for four
more articles). For one study, there were two publica-
tions reporting different aspects of the study w22, 24x.
Both publications were used to extract data regarding
the methods used and the results reported. Thus, finally,
12 studies were included in this review.
Publication bias
To investigate the amount of publication bias for our
study, a funnel plot was made (Fig. 1). The plot shows
the relationship between the distribution of the point
estimates of the association between obesity and hip
OA, and the sample size (n). Although the plot shows
a more or less equal distribution, there is a lack of small
studies showing an inverse association.
FIG. 1. Funnel plot showing the distribution of OR according
to sample size. Of the 12 studies included, only nine provided
sufficient data to be included in this plot. Three studies could
not be included as no OR was available w26, 28, 29x. The
numbers in the body of the graph are the reference numbers of
the articles.
1.
2.
5.
3.
4.
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TABLE 2. Details of the studies included in this review
Author Population Assessment of hip OA Adjusted for Resultsb Score
Cohort studies
Gelber w19x Male medical students (USA) classes
1948–1964 age 20–29 yr (n = 1180)
Follow-up 36 (31–47) yr
Clinical (self-reported
at follow-up by
questionnaire)
Age, physical activity,
joint injury
BMI <23, OR 1 (index)
BMI 23–25, OR 1.10 (0.4–2.8)
BMI >25, OR 1.03 (0.4–2.6)
Data on age 40–49 yr
75
Case–control studies
Vingard w24x,
Olsen w22x
1. All men from Stockholm with a THR between
1984 and 1988, aged 40–70 yr (n = 239)
2. Random selection of men from Stockholm
aged 40–70 yr (n = 302)
aTHR in that period Age, smoking
occupation, sports
BMI (25, OR 1 (index)
BMI >25, OR 2.3 (1.2–4.4)
Data on age 50 yr
77
Oliveria w21x 1. Females of the Fallon Community Health Plan
(USA) aged 20–89 yr with hip OA (n = 134)
2. Random selection of women from the
Fallon Community Health Plan (n = 134)
aClinical (ACRupain, stiffness,
soreness, aching, discomfort,
swelling, tenderness) and X-ray
(osteophytes, hypertrophic changes)
Age, gender, HRT,
smoking, consumption
of medical services
BMI (24, OR 1 (index)
BMI 24–28, OR 3.4 (0.4–25.6)
BMI >28, OR 1.4 (0.1–17.5)
69
Vingard w25x 1. All women from South Sweden who had
THR between 1992 and 1994 (n = 230)
2. Random selection of women from the same
area without known hip disorders (n = 273)
aTHR in that period Age, number of children,
sports, HRT,
occupation, smoking
BMI (20, OR 1 (index)
BMI 20–25, OR 1.2 (0.5–2.8)
BMI >25, OR 2.1 (0.9–4.6)
Data on age 50 yr
69
Roach w23x 1. Males in Chicago with THR or
signs of hip OA on X-ray (n = 99)
2. Same population without signs of
hip OA on i.v. urograph (n = 233)
aClinical (pain) X-rayu
i.v. urograph
(JSW) or THR
Various confounders BMI (27.8, OR 1
BMI >27.7, OR 2.0 (1.0–4.0)
Data on age 40 yr
46
Cross-sectional studies
Cooper w18x 1. Patients on waiting list for THR at 2 clinics
in England, aged >45 yr (n = 611)
2. Patients with the same GP, without previous
hip surgery because of arthrosis (n = 611)
Waiting list for THR Age, gender, Heberden’s
nodes, hip trauma
BMI (25, OR 1 (index)
BMI 25–28, OR 1.3 (0.95–1.7),
bilateral OR 1.3 (0.9–1.8)
BMI 028, OR 1.6 (1.2–2.2),
bilateral OR 1.7 (1.2–2.4)
69
Heliovaara w20x Finnish open population
(n = 7217), aged 030 yr
Documented history
of hip OA or definite
physical findings
Age, gender, trauma,
stress at work
BMI <25, OR 1 (index)
BMI 25–30, OR 1.5 (1.1–1.9),
bilateral OR 1.4 (1.0–2.0)
BMI 30–35, OR 2.0 (1.5–2.7)
bilateral OR 2.3 (1.5–3.5)
60
Van Saase w28x Open population of Zoetermeer (The
Netherlands), aged 45–64 yr (n = 2168)
X-ray (Kellgren
and Lawrence)
Age, gender ‘Association is absent’ 60
Hartz w26x Open population of the USA aged
40–69 yr (HANES I) (n = 4225)
X-ray (Kellgren
and Lawrence)
Age, gender, race ‘Relative weight was weakly
associated with hip OA’
50
Tepper w4x Open population of USA aged 55 yr
(NHANES-1) (n = 2358)
X-ray (Kellgren
and Lawrence)
Gender, race, age,
education
BMI (27, OR 1 (index)
BMI >27, OR 1.02 (0.6–1.7),
bilateral OR 2.0 (0.97–4.2)
50
Kraus w27x 1. Patients referred by physicians with hip OA
to one clinic in USA (n = 100)
2. Patients at the same hospital at department
of surgery or general medicine (n = 100)
aClinical (patients) X-ray? Age, gender, race <20% above ideal weight, OR 1
<20% above ideal weight,
020% OR 2.7 (1.4–5.4)
46
Saville w29x 1. Patients with primary hip OA at a department of
special surgery (USA), aged 15–78 yr (n = 121)
2. US normals for height and weight
3. Patients from the same department
without hip OA (n = 141)
aClinical (patients) X-ray
(JSN and subchondral
bone sclerosis)
‘Body weight distribution
among patients with hip OA
was similar to that of normal
men and women in the US’
15
aAssessment of hip OA was only carried out for cases. bFigures in parenthesis are the confidence intervals. 1, cases; 2 and 3, control group.
NHANES, National Health and Nutrition Examination Survey; JSN, joint space narrowing; JSW, joint space width; i.v., intravenous; HRT, hormone replacement therapy.
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Description of the studies
Table 2 gives a detailed description of the characteristics
of the included studies. Only five studies had a longi-
tudinal design, viz. one prospective cohort study w19x
and four retrospective case–control studies w21–23, 25x,
whereas the remaining seven studies reported only cross-
sectional associations between obesity and the presence
of OA w4, 18, 20, 26–29x. In two of the 12 studies, the
studied population was hospital-based w23, 27x. The
other 10 studies were population-based.
Three studies included only males w19, 22, 23x and two
others included only females w21, 25x. The ages of the
studied populations diverge, but most studies investi-
gated subjects aged 40 yr and older. All studies were
carried out in the USA w4, 19, 21, 23, 26, 27, 29x or in
Northern Europe w18, 20, 22, 25, 28x. Most of the studies
determined obesity with the BMI. One study used the
ideal body weight w27x and another study used rela-
tive weight w26x; both measurements were derived from
a normal distribution of height and weight in the
population w30x. One study used weight only w29x.
The method of assessment of hip OA varied in several
studies. Two studies relied on clinical information only
w19, 20x, three other studies used an X-ray score only
w4, 26, 28x and another three studies used a combination
of these two w21, 23, 29x as an outcome measure. Three
studies used a (total) hip replacement (THR) or waiting
for a THR in a specific period as an outcome w18, 22, 25x.
One study did not describe clearly how hip OA was
assessed; i.e. whether it was clinical only or also used
X-ray information w27x.
Results of the studies included
Nine of the 12 studies showed exact data of the out-
comes; the other three described the outcome in global
terms only w26, 28, 29x.
Seven studies showed a positive association between
obesity and hip OA wodds ratio (OR)01.25x w18, 20, 21,
23–25, 27x; in five studies the association was statisti-
cally significant w18, 20, 23, 24, 27x, indicating that
subjects with a higher BMI (approximately >25) have
an increased risk of developing hip OA. Four of these
seven studies had a case–control design and the other
three a cross-sectional design. Three studies showed
a weak positive relationship wrelative risk (RR) or OR
1–1.25x w4, 19, 26x; one of these studies had a prospective
cohort design.
There were no studies reporting a negative associ-
ation. There were four studies reporting outcomes on
the association between moderate obesity (BMI >25)
and hip OA, but also between more severe obesity (BMI
>27) and hip OA w18, 20, 21, 25x. Three of these studies
showed a clear dose–response relationship w18, 20, 25x.
Three studies also investigated the relationship of the
BMI and the presence of bilateral disease w4, 18, 20x. The
outcomes show that the strength of the relationship was
similar to that found for unilateral hip OA.
In contrast with the nine studies which used clinical
information (e.g. physical complaints, need for a THR)
for the diagnosis of hip OA, the three studies using only
an X-ray as evidence for hip OA w4, 26, 28x reported no
association or only a very weak positive association with
hip OA.
Methodological quality assessment
The two reviewers scored 404 items and agreed on
378 items (94%, k = 0.87). The 26 disagreements were
resolved in a single consensus meeting. Table 3 shows
the studies in order of their methodological quality
score, subdivided into the different types of study design
(i.e. cohort, case–control and cross-sectional). The
TABLE 3. Quality scores of the studies
Criterion
1 2 3 4 5a 6 7 8 9 10 11 12a 13 14 15 16a 17a 18 19
Individual
score
Total
obtainable
Total
score
Cohort studies
Gelber w19x 1 na 1 na 1 1 na 1 1 0 0 0 1 1 1 0 1 0 1 9 12 75%
Case–control studies
Olsen w22x,
Vingard w24x
1 1 1 1 1 0 1 1 0 1 1 1 0 na na na 1 1 1 10 13 77%
Oliveria w21x 1 1 1 1 0 0 1 1 0 0 1 1 0 na na na 1 1 1 9 13 69%
Vingard w25x 1 1 1 1 1 0 1 0 0 1 1 1 0 na na na 1 1 1 9 13 69%
Roach w23x 0 1 0 0 1 0 1 0 0 1 1 1 0 na na na 1 1 1 6 13 46%
Cross-sectional studies
Cooper w18x 1 1 1 0 1 0 1 0 1 1 1 1 0 na na na 1 1 1 9 13 69%
Heliovaara w20x 0 na 1 na 1 0 na 0 1 1 1 0 0 na na na 1 1 1 6 10 60%
van Saase w28x 0 na 0 na 0 1 na 0 1 1 1 1 0 na na na 1 1 1 6 10 60%
Hartz w26x 0 na 0 na 1 0 na 0 1 1 1 1 0 na na na 1 1 1 5 10 50%
Tepper w4x 0 na 0 na 1 0 na 0 1 1 1 1 0 na na na 0 1 1 5 10 50%
Kraus w27x 1 1 1 1 1 0 1 0 0 0 0 0 0 na na na 1 0 1 6 13 46%
Saville w29x 1 0 0 0 0 0 1 0 0 0 0 0 0 na na na 1 0 0 2 13 15%
Each item was scored 1 when it met the specified criteria listed in Table 1. If it did not meet the criteria or was not described at all, a score of 0
was assigned. Positive scores were summed to give an overall internal validity score.
aInformativity item; not included in the analysis.
na, not applicable.
Obesity and hip OA 1159
scores ranged from 15 to 77% of the maximum
obtainable score for each study design. The mean
quality score was 57%.
The participation rates of the studied populations
(Table 1, items 3, 4) were very low; the criteria were
fulfilled by three of the four case–control studies and the
cohort study but by only one out of the seven cross-
sectional studies. In contrast with the assessment of
obesity, for which there was almost always an identical
or comparable assessment within the different groups of
the population (Table 1, item 7), the assessment of hip
OA (item 9) diverged substantially. In studies with a
cohort as study base (longitudinal and cross-sectional
data), there was always an identical assessment of hip
OA. In case–control studies (with longitudinal and
cross-sectional data), however, the assessment of hip OA
in six of the seven studies was carried out in the patients
but not (or differently) in the controls w21–23, 25, 27, 29x.
One of the main concerns about the internal validity
of observational studies is that of confounding w31x.
When there is confounding, the observed effect may
occur due to a combination of several determinants that
are prevalent in the study population. In hip OA two
potential confounders are age and gender, and there
should be correction for at least these determinants in
the individual studies. Only one study did not meet this
criterion w29x; all the others did, by means of matching,
restriction or adjustment in the analysis.
No correlation was found between the quality score and
the study outcome (Fig. 2) (Pearson correlation= 20.04,
P = 0.9).
Three of the 12 studies could not be plotted due to a
lack of precise data on the OR or RR. Of these, van
Saase et al. w28x achieved a quality score of 67% and
reported no association between obesity and hip OA.
Hartz et al. w26x scored 56% and reported a weak
association, whereas Saville and Dickson w29x achieved a
score of 17% and showed no association between obesity
and hip OA.
Best evidence synthesis
According to Chalmers and colleagues w15x, the cut-off
point for high-quality studies was set at the mean of the
quality scores, so a study was considered to be of high
quality if the methodological quality score was 060%.
There were five longitudinal studies, and four of them
reached the level of high quality. The high-quality
cohort study reported an OR of 1.03 w95% confidence
interval (CI) 0.41–2.60x, whereas the three high-quality
case–control studies reported an association of 2.3 (95%
CI 1.2–4.4), 3.4 (95% CI 0.4–25.6) and 2.1 (95% CI
0.9–4.6). This means that there is moderate evidence for
a positive association between obesity and hip OA, with
an OR of approximately 2.
In the subgroup of studies reporting the association
between bilateral hip OA and obesity, only three cross-
sectional studies were found, of which two reached the
level of high quality w18, 20x. This means that, with the
best-evidence synthesis, we can conclude that there is
only limited evidence for a positive association between
obesity and the occurrence of bilateral hip OA. The
strength of the association is comparable to the strength
found for unilateral hip OA.
For the subgroup of articles assessing hip OA on
clinical information (e.g. physical complaints, need for
a THR), six w18–22, 25x of the nine articles reached
the level of high quality. One had a cohort design w19x,
three a case–control design w21, 22, 25x and two a cross-
sectional design w18, 20x. The reported ORs were 1.03,
1.4, 2.3, 2.1, 1.6 and 2.0. This means that there is
moderate evidence for a positive relationship between
clinically assessed hip OA and obesity.
All three studies that assessed hip OA with radio-
logical parameters had a cross-sectional design w4, 26, 28x.
The reported outcomes were ‘absence of an association’,
‘a weak association’ and an OR of 1.02. One of them
reached the level of high quality w32x, so there is limited
evidence for no association in the subgroup of
radiologically assessed hip OA.
Discussion
In this systematic review, we summarized the evidence
available in the literature on the influence of obesity
on the development of OA of the hip. On the basis of
this evidence, we may conclude that there is moderate
evidence for a positive association between hip OA and
obesity. For the subcategory of bilateral hip OA, only
FIG. 2. Quality score of nine of the 12 studies in relation to
OR. Three studies could not be included as no OR was
available w26, 28, 29x. The numbers in the body of the graph are
the reference numbers of the articles.
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limited evidence was found. The strength of association
found in this subgroup was comparable to the strength
found in the overall conclusion.
For a subcategory of articles in which hip OA was
assessed clinically, moderate evidence was also found
for a positive association, in contrast to radiologically
assessed hip OA, for which limited evidence for no
association was found. This review may, however, suffer
from several restrictions.
Identification and selection of the literature
Although we put much effort into identifying the rele-
vant articles, our literature search might have had some
limitations. Some relevant articles may have been missed
because they used other key words or had unclear
abstracts, and not all published articles are indexed
in databases. Besides, we excluded articles written in
languages other than English, Dutch, German, French,
Danish, Norwegian and Swedish.
The presumed publication bias found in our results
(Fig. 1) can be explained by a selection of studies that
were published for their ‘exciting’ positive results that
satisfy current dogma. When assessing the funnel plot,
we have to keep in mind that three of the 11 studies
could not be included in the analysis due to insufficient
data to deduce a point estimate w26, 28, 29x.
Unfortunately, only one prospective study of the
association between obesity and hip OA could be found.
This design is known to be the most valid type of
observational studies. Having more data from this type
of design would have allowed us to provide a more valid
and precise conclusion. The decision to include cross-
sectional studies is based on the results of several studies
reporting a similarity between current BMI and histori-
cal BMI in patients with hip OA w25, 33, 34x. Our data
support these findings. We acknowledge, however, that
the strength of the evidence of cross-sectional studies is
much lower than the evidence provided by prospective
cohort studies and, to a lesser extent, case–control
studies.
Quality assessment and best-evidence synthesis
The quality assessment was challenging because no
tested and validated criteria lists have been published for
observational studies in the field of OA. Also, limited
data were found on performing a best-evidence synthesis
with observational studies. Therefore we have presented
them in a reproducible manner, and the criteria we used
were relatively strict.
A very notable item in the quality assessment was the
difference in the assessment of hip OA between the
patients and controls in the case–control studies (either
longitudinal or cross-sectional). Most studies took as
cases all patients with hip OA and as controls a sample
of the underlying population, but without screening
them for hip OA. This means that some controls might
have had hip OA, so these studies would be biased
towards a null result.
There have been suggestions that controls do not need
to be evaluated for the occurrence of the disease, but
rather must represent the base population, which will
include such cases w35x. Considering the fact that there
are still contradictory opinions on this subject, we prefer
the classical point of view, namely that controls must be
free of the disease under study.
The most interesting finding in our study is the
difference found between clinically assessed and radi-
ologically assessed hip OA. Whereas the former group
of studies shows that obese people suffer more from hip
OA, the latter shows that there is no difference in the
presence of hip OA, between obese and non-obese
people. This may suggest that obese people suffer more
from the same radiological degree of hip OA than non-
obese people do. Thus, obese patients may have more
hip complaints at an equal radiological stage, due to the
weight on the hip joint, and therefore qualify earlier for
THR than non-obese patients. Unfortunately, there are
only a few studies reporting on weight loss in relation to
knee OA, and none in relation to hip OA, to support
this explanation w36, 37x.
In view of the moderate evidence for an association,
knowledge of the origin of the relationship between hip
OA and obesity is important. Future research, especially
well-designed prospective cohort studies with adequate
follow-up time, will not only strengthen the conclusion
of this review but might also throw light on the cause of
this relationship.
Conclusion
This systematic review shows that in the literature, there
is moderate evidence for a positive influence of obesity
on the development of hip OA.
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